title: [Coronary stents: 30 years of medical progress].
abstract: The history of interventional cardiology has been marked by several technologic revolutions since the late 1970s. The first key step was the use of inflatable balloon angioplasty as an alternative to CABG surgery for coronary revascularization, followed by intracoronary delivery of bare metal stent (BMS) and drug eluting stents (DES) to drastically reduce intracoronary restenosis observed with BMS. Improved stents platforms and polymers (absorbable or biocompatible) led to a dramatic reduction in the rate of late stent thrombosis. Self-expanding stents are now available to improve stent a position especially in acute myocardial infarction. The emergence of new fully bioabsorbable stents that can be combined with antiproliferative drugs is the ongoing revolution. A new generation of stents is continuously improving and likely to become the ideal stent for coronary revascularization in the near future.
authors.affiliation: Institut de cardiologie, ACTION (www.action-coeur.org) group, Inserm CMR937, hôpital Pitié-Salpêtrière (AP-HP), université Paris 6, 47, boulevard de l'Hôpital, 75013 Paris, France.
authors.forename: Johanne
authors.initials: J
authors.lastname: Silvain
authors.affiliation: Institut de cardiologie, ACTION (www.action-coeur.org) group, Inserm CMR937, hôpital Pitié-Salpêtrière (AP-HP), université Paris 6, 47, boulevard de l'Hôpital, 75013 Paris, France - Service de cardiologie, université Montpellier 1, hôpital universitaire Carémeau, Nîmes, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Cayla
authors.affiliation: Institut de cardiologie, ACTION (www.action-coeur.org) group, Inserm CMR937, hôpital Pitié-Salpêtrière (AP-HP), université Paris 6, 47, boulevard de l'Hôpital, 75013 Paris, France.
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Collet
authors.affiliation: Service pharmacie UFDMS, hôpital Pitié-Salpêtrière (AP-HP), Paris, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Fargeot
authors.affiliation: Institut de cardiologie, ACTION (www.action-coeur.org) group, Inserm CMR937, hôpital Pitié-Salpêtrière (AP-HP), université Paris 6, 47, boulevard de l'Hôpital, 75013 Paris, France.
authors.forename: Gilles
authors.initials: G
authors.lastname: Montalescot
mesh_terms: D020341:Absorbable Implants; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D001807:Blood Vessel Prosthesis / Q000009:adverse effects / Q000639:trends*; D003331:Coronary Vessels; D054855:Drug-Eluting Stents; D004867:Equipment Design; D004868:Equipment Failure; D006801:Humans; D009203:Myocardial Infarction / Q000601:surgery; D011108:Polymers / Q000737:chemistry; D015607:Stents / Q000009:adverse effects / Q000706:statistics & numerical data / Q000639:trends
chemical_list: D011108:Polymers